Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2020 | 06-2019 | 06-2017 | 06-2007 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -8,939 | -9,249 | N/A | N/A |
| Depreciation Amortization | 112 | 119 | N/A | N/A |
| Accounts receivable | 17 | -24 | N/A | N/A |
| Other Working Capital | 358 | 282 | N/A | N/A |
| Other Operating Activity | 1,077 | 2,247 | 0 | 0 |
| Operating Cash Flow | $-7,375 | $-6,624 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 3,833 | -2,062 | N/A | N/A |
| PPE Investments | -42 | -27 | N/A | N/A |
| Investing Cash Flow | $3,791 | $-2,088 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | N/A | 205 | N/A | N/A |
| Other Financing Activity | -31 | 0 | 0 | 0 |
| Financing Cash Flow | $-31 | $205 | $N/A | $N/A |
| Exchange Rate Effect | -416 | 17 | N/A | N/A |
| Beginning Cash Position | 9,837 | 18,328 | N/A | N/A |
| End Cash Position | 5,806 | 9,837 | N/A | N/A |
| Net Cash Flow | $-4,031 | $-8,491 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -7,375 | -6,624 | N/A | N/A |
| Capital Expenditure | -43 | -27 | N/A | N/A |
| Free Cash Flow | -7,417 | -6,651 | 0 | 0 |